A UK cell therapy research centre delivered by ISG has been described as world-beating by the company’s Chief Operating Officer. Cell Therapy Catapult’s Dr Stephen Ward said the facility, completed in March 2014, was a success with staff and the company’s global clientele.
“What really stands out when we have international visitors is the ‘wow’ factor,” Dr Ward said. “Global companies have said this is not world-leading, this is world-beating - so we really have made a mark in terms of the design of what we have delivered here.”
Dr Ward was speaking in an exclusive interview recorded by ISG six months after the company had moved into their new location. The unit, located on the 12th floor of the 30-storey Tower Wing building at London’s Guy’s Hospital, was completed in 22 weeks and involved working within a live hospital environment. The 25,000 sq ft facility combines a state-of-the-art laboratory with open plan office space, a kitchen, break-out areas and meeting rooms with high-specification audio-visual equipment.
Cell Therapy Catapult is part of the government’s Catapult innovation scheme, which provides funding to businesses, scientists and engineers looking to manufacture and develop new technologies for the marketplace. The facility was officially opened by Business Secretary Vince Cable in June 2014.
Dr Ward said the ISG team went the extra mile to ensure a highly-technical project was completed on time. “I can’t speak highly enough of the core team they had here,” he said. “ISG [provided an] extremely committed ground crew. I remember just before Christmas the guys running up flights of stairs to try and get sign off before the Christmas shutdown.
“What they [ISG] have done from the bottom up is deliver what we wanted [to a] really high quality, and they really went the extra mile to deliver this on time. [This was] important for us as we had to move out of our temporary premises and it really was down to a day-specific situation.”
The project was delivered by ISG’s research and development team led by Engineering Services Divisional Director, Paul Sharp. Since the handover of Cell Therapy Catapult, the team was selected to work on two further Catapult projects: Future Cities Catapult in Farringdon, and the Digital Catapult scheme, based close to the Silicon Roundabout in London.